Market Cap (In SEK)
240.4 Million
Revenue (In SEK)
6.24 Million
Net Income (In SEK)
-77.83 Million
Avg. Volume
2.36 Million
- Currency
- SEK
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.1688-0.599
- PE
- -3.23
- EPS
- -0.07
- Beta Value
- 1.479
- ISIN
- SE0009268717
- CUSIP
- -
- CIK
- -
- Shares
- 1063740000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Mr. Aamir Mahmood
- Employee Count
- -
- Website
- https://www.acarix.com
- Ipo Date
- 2016-12-19
- Details
- Acarix AB (publ), a medical technology company, develops and commercializes diagnostic tests for cardiovascular diseases in Germany, Sweden, the Middle East, Switzerland, Austria, and internationally. The company offers CADScor System, a non-invasive and ultra-sensitive analytical device for the diagnosis of coronary artery disease. Acarix AB (publ) was founded in 2009 and is headquartered in Malmö, Sweden.
More Stocks
-
GICSABGrupo Gicsa S.A.B. de C.V.
GICSAB
-
TDWTidewater Inc.
TDW
-
LAXMIMACHLakshmi Machine Works Limited
LAXMIMACH
-
HISEF
-
ENZYEnzymatica AB (publ)
ENZY
-
ACONAclarion, Inc.
ACON
-
KEIL
-
PNRPantoro Limited
PNR